We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Janssen’s Spravato (esketamine) spray—approved by the FDA in March for treatment-resistant depression —isn’t cost-effective at its listed price, a nonprofit drug price watchdog says. Read More
President Trump on Monday signed what he termed a “breakthrough” executive order requiring hospitals to inform patients of the prices they hash out with insurers. Read More
The defendants are accused of using cryptocurrency on the so-called dark web to import synthetic opioids and make pills on industrial-grade machinery. Read More